Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Rev Sci Tech ; 24(3): 909-20, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16642761

RESUMEN

Analysis of retrospective quantitative sheep pox epidemiological data from the Government Animal Husbandry Department, Karnataka, India, covering 24 years revealed significant information on sheep pox. The state has a dense sheep population including some valuable breeds. Data revealed the endemicity of the disease: there were a considerable number of outbreaks and attacks, high mortality and case fatality rates and low immunisation coverage. None of the years studied were free from infection. Temporally, the disease was most prevalent between November and May. Spatially, the disease was recorded in 19 out of 27 districts; in some of these districts sheep pox was highly endemic, in some it was endemic at low levels and in the remaining districts outbreaks occurred sporadically. Environmental factors influenced disease occurrence. Vaccine production met only one tenth of the requirement, and its peak utilisation was in the dry season.


Asunto(s)
Capripoxvirus , Infecciones por Poxviridae/veterinaria , Enfermedades de las Ovejas/epidemiología , Vacunas Virales/administración & dosificación , Animales , Cruzamiento , Clima , Brotes de Enfermedades/veterinaria , Femenino , India/epidemiología , Masculino , Infecciones por Poxviridae/epidemiología , Infecciones por Poxviridae/mortalidad , Estudios Retrospectivos , Estaciones del Año , Ovinos
2.
Trop Anim Health Prod ; 36(4): 307-20, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15241965

RESUMEN

A classical live attenuated sheep pox vaccine was prepared using the Ranipet strain of sheep pox virus (SPV) at the 50th passage in a secondary lamb testicular cell system. The TCID50 and RD50 were 10(9.63)/ml and 10(9.51)/ml. respectively. The SID50 of SPV challenge virus was 10(5)/ml. The vaccine was found to have no adverse effects in laboratory animals, and was safe and effective in SPV seronegative lambs. In the field, 660 sheep were vaccinated with an immunizing dose containing 1 x 10(2) TCID50. Randomly selected vaccinated sheep mounted good cell-mediated immunity and humoral responses as measured by glucose utilization test and serum neutralization test, respectively, for the study period of 6 months.


Asunto(s)
Capripoxvirus/inmunología , Infecciones por Poxviridae/prevención & control , Infecciones por Poxviridae/veterinaria , Enfermedades de las Ovejas/prevención & control , Enfermedades de las Ovejas/virología , Vacunas Virales/inmunología , Vacunas Virales/uso terapéutico , Animales , Temperatura Corporal , Femenino , Glucosa/metabolismo , Cobayas , Inmunización/métodos , Inmunización/veterinaria , Masculino , Ratones , Pruebas de Neutralización/veterinaria , Infecciones por Poxviridae/inmunología , Infecciones por Poxviridae/virología , Ovinos , Enfermedades de las Ovejas/inmunología , Vacunas Atenuadas/efectos adversos , Vacunas Atenuadas/inmunología , Vacunas Atenuadas/uso terapéutico , Vacunas Virales/efectos adversos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...